Formation, bioavailability and organoleptic properties of an inclusion complex of femoxetine with β-cyclodextrin
- 1 August 1984
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 21 (1) , 51-60
- https://doi.org/10.1016/0378-5173(84)90202-3
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Hepatic Elimination of Femoxetine in PigActa Pharmacologica et Toxicologica, 2009
- A Controlled Double-blind Study of Femoxetine and Amitriptyline in Patients with Endogenous DepressionPharmacopsychiatry, 1982
- A double-blind controlled trial of the selective serotonin uptake inhibitor femoxetine and amitriptyline in depressionNordisk Psykiatrisk Tidsskrift, 1982
- Pharmaceutical Applications of Cyclodextrin ComplexationsYAKUGAKU ZASSHI, 1981
- Cyclodextrin Inclusion Compounds in Research and IndustryAngewandte Chemie International Edition in English, 1980
- Pharmacokinetics of Femoxetine in ManActa Pharmacologica et Toxicologica, 1979
- Reduction of whole blood serotonin in depressed patients treated with a new, selective serotonin-uptake inhibitor, femoxetinePsychopharmacology, 1979
- Determination of (+)-(3R),(4S)-3-[(4-methoxyphenoxy)methyl]-1-methyl-4-phenylpiperidine hydrochloride (FG 4963) in biological fluids using competition for adsorption to glassJournal of Chromatography A, 1977
- Antidepressant evaluation and the pharmacological actions of FG4963 in depressive patientsEuropean Journal of Pharmacology, 1977
- A Spectrophotometric Investigation of the Interaction of Iodine with Aromatic HydrocarbonsJournal of the American Chemical Society, 1949